Research Article
Paraoxonase1 Genetic Polymorphisms in a Mixed Ancestry African Population
Table 3
Associations of genotypes with PON1 and oxidative stress markers.
| Characteristics | PON1 rs662 | PON1 rs854560 | Overall | QQ192 | Q192R | 192RR | value | 55MM |
L55M | LL55 | value |
| | 53 (14.3) | 191 (51.6) | 126 (34.1) | | 246 (66.5) | 114 (30.8) | 10 (2.7) | | 370 | Men, (%) | 12 (22.6) | 49 (25.7) | 33 (26.2) | 0.878 | 66 (26.8) | 27 (23.7) | 1 (10) | 0.429 | 94 | Diabetes, (%) | 17 (32.1) | 67 (35.1) | 28 (22.2) | 0.049 | 71 (28.9) | 36 (31.6) | 5 (50.0) | 0.338 | 112 | Hypertension, (%) | 31 (58.5) | 100 (52.4) | 56 (44.4) | 0.177 | 124 (50.4) | 56 (49.1) | 7 (70.0) | 0.447 | 187 | PON1 conc (µg/mL) | 104 [94–117] | 101 [78–112] | 94 [71–111] | 0.015 | 98 [74–113] | 98 [81–111] | 105 [95–112] | 0.429 | 98 [77–112] | PONase (U/L) | 130 [93–182] | 189 [146–222] | 185 [144–222] | <0.0001 | 183 [132–222] | 185 [132–220] | 119 [96–160] | 0.059 | 183 [130–220] | AREase (kU/L) | 97 [72–119] | 108 [85–133] | 108 [84–132] | 0.346 | 104 [82–132] | 108 [83–133] | 125 [120–137] | 0.252 | 108 [83–132] | FRAP (µM) | 651 [526–754] | 702 [541–832] | 677 [559–831] | 0.381 | 677 [543–840] | 677 [547–763] | 674 [567–755] | 0.827 | 677 [545–817] | TEAC (nM) | 1206 [837–1442] | 1298 [946–1632] | 1338 [971–1644] | 0.053 | 1299 [934–1645] | 1268 [945–1581] | 1303 [1237–1330] | 0.774 | 1289 [941–1626] | Ox-LDL (ng/mL) | 3791 [2227–6155] | 4695 [3361–6009] | 4142 [2972–5298] | 0.029 | 4281 [3184–5622] | 4602 [3049–5842] | 2682 [1463–6314] | 0.501 | 4284 [3082–5719] | TBARS (nM) | 1840 [942–3042] | 2424 [1844–3148] | 2223 [1598–2978] | 0.006 | 2298 [1640–3128] | 2282 [1625–3042] | 1114 [950–2822] | 0.221 | 2282 [1622–3116] |
|
|
PON1: Paraoxonase 1; PONase: paraoxonase activity; AREase: arylesterase activity; FRAP: ferric reducing ability of plasma; TEAC: Trolox equivalent antioxidant capacity; Ox-LDL: oxidized LDL; TBARS: thiobarbituric acid reactive substances.
|